---
title: "ENDRA Life Sciences Inc. (NDRA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NDRA.US.md"
symbol: "NDRA.US"
name: "ENDRA Life Sciences Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T08:35:31.348Z"
locales:
  - [en](https://longbridge.com/en/quote/NDRA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NDRA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NDRA.US.md)
---

# ENDRA Life Sciences Inc. (NDRA.US)

## Company Overview

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [endrainc.com](https://endrainc.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.95 | 84 | - | - | - |
| PB | 3.88 | 89 | 29.33 | 2.96 | 2.18 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-06T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.59 |
| Highest Target | 27.00 |
| Lowest Target | 27.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NDRA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NDRA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/NDRA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NDRA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**